| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 40 | 2023 | 2159 | 4.570 |
Why?
|
| Muscle, Smooth, Vascular | 30 | 2023 | 409 | 3.420 |
Why?
|
| PPAR gamma | 13 | 2019 | 182 | 2.730 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 20 | 2023 | 959 | 2.310 |
Why?
|
| Tumor Microenvironment | 9 | 2021 | 428 | 2.300 |
Why?
|
| Myocytes, Smooth Muscle | 17 | 2023 | 236 | 1.940 |
Why?
|
| Phospholipases A | 24 | 2006 | 95 | 1.880 |
Why?
|
| PTEN Phosphohydrolase | 10 | 2020 | 140 | 1.790 |
Why?
|
| Platelet-Derived Growth Factor | 10 | 2020 | 80 | 1.290 |
Why?
|
| Animals | 144 | 2023 | 31565 | 1.240 |
Why?
|
| Mitogen-Activated Protein Kinases | 10 | 2020 | 269 | 1.230 |
Why?
|
| Cell Proliferation | 21 | 2021 | 2173 | 1.180 |
Why?
|
| Carcinoma, Lewis Lung | 2 | 2019 | 13 | 1.170 |
Why?
|
| Complement Activation | 4 | 2019 | 337 | 1.140 |
Why?
|
| Adenocarcinoma | 6 | 2017 | 787 | 1.100 |
Why?
|
| Mice | 61 | 2023 | 14841 | 1.020 |
Why?
|
| Rats | 67 | 2019 | 4913 | 0.970 |
Why?
|
| Myeloid Cells | 2 | 2019 | 126 | 0.950 |
Why?
|
| Cell Line, Tumor | 21 | 2021 | 2698 | 0.910 |
Why?
|
| Cyclooxygenase 2 | 9 | 2010 | 164 | 0.880 |
Why?
|
| Signal Transduction | 29 | 2021 | 4501 | 0.870 |
Why?
|
| Neointima | 3 | 2022 | 13 | 0.870 |
Why?
|
| Dinoprostone | 13 | 2016 | 183 | 0.870 |
Why?
|
| B7-H1 Antigen | 4 | 2023 | 137 | 0.850 |
Why?
|
| Actins | 10 | 2018 | 376 | 0.840 |
Why?
|
| Macrophages | 7 | 2021 | 1259 | 0.830 |
Why?
|
| Mice, Inbred C57BL | 24 | 2023 | 4680 | 0.830 |
Why?
|
| Lipid Metabolism | 3 | 2023 | 441 | 0.830 |
Why?
|
| Serum Response Factor | 4 | 2016 | 29 | 0.810 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2023 | 153 | 0.800 |
Why?
|
| Programmed Cell Death 1 Receptor | 3 | 2020 | 193 | 0.800 |
Why?
|
| Adaptive Immunity | 3 | 2023 | 154 | 0.780 |
Why?
|
| Trans-Activators | 2 | 2020 | 366 | 0.780 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2020 | 350 | 0.760 |
Why?
|
| Promoter Regions, Genetic | 14 | 2020 | 1131 | 0.760 |
Why?
|
| Immunotherapy | 4 | 2023 | 473 | 0.760 |
Why?
|
| Receptors, Complement | 2 | 2021 | 111 | 0.740 |
Why?
|
| Antineoplastic Agents, Immunological | 3 | 2019 | 152 | 0.730 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 8 | 1997 | 170 | 0.720 |
Why?
|
| Arginine Vasopressin | 10 | 2003 | 46 | 0.720 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2021 | 28 | 0.710 |
Why?
|
| Complement C5a | 2 | 2019 | 59 | 0.700 |
Why?
|
| Kidney | 13 | 2023 | 1182 | 0.670 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2018 | 607 | 0.670 |
Why?
|
| Chemokine CXCL12 | 2 | 2011 | 74 | 0.660 |
Why?
|
| Mice, Knockout | 21 | 2023 | 2562 | 0.650 |
Why?
|
| Cells, Cultured | 29 | 2019 | 3861 | 0.650 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 6 | 2019 | 228 | 0.650 |
Why?
|
| Disease Models, Animal | 20 | 2021 | 3498 | 0.650 |
Why?
|
| Vascular Remodeling | 5 | 2022 | 153 | 0.650 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2021 | 577 | 0.630 |
Why?
|
| Vascular System Injuries | 2 | 2023 | 66 | 0.620 |
Why?
|
| Epithelial Cells | 9 | 2018 | 946 | 0.610 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2020 | 1142 | 0.610 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 167 | 0.580 |
Why?
|
| Enzyme Activation | 25 | 2008 | 771 | 0.550 |
Why?
|
| Arachidonate 5-Lipoxygenase | 2 | 2019 | 43 | 0.550 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 155 | 0.550 |
Why?
|
| Interferon-gamma | 2 | 2020 | 719 | 0.540 |
Why?
|
| Nuclear Proteins | 2 | 2023 | 591 | 0.540 |
Why?
|
| Cytosol | 12 | 2006 | 201 | 0.520 |
Why?
|
| RNA Interference | 6 | 2014 | 431 | 0.520 |
Why?
|
| Cell Movement | 8 | 2014 | 863 | 0.510 |
Why?
|
| Transfection | 14 | 2014 | 863 | 0.490 |
Why?
|
| Inflammation | 7 | 2018 | 2464 | 0.490 |
Why?
|
| Disease Progression | 8 | 2019 | 2371 | 0.490 |
Why?
|
| Intramolecular Oxidoreductases | 5 | 2008 | 57 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-fos | 3 | 2012 | 165 | 0.480 |
Why?
|
| Protein Kinases | 12 | 2006 | 304 | 0.470 |
Why?
|
| Glomerular Mesangium | 6 | 1995 | 17 | 0.470 |
Why?
|
| Eicosanoids | 2 | 2013 | 54 | 0.470 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2017 | 959 | 0.470 |
Why?
|
| Mice, Transgenic | 12 | 2020 | 1947 | 0.470 |
Why?
|
| Group IV Phospholipases A2 | 5 | 2017 | 45 | 0.470 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 3 | 2023 | 209 | 0.460 |
Why?
|
| Gene Expression Regulation | 10 | 2019 | 2321 | 0.450 |
Why?
|
| Atherosclerosis | 4 | 2023 | 342 | 0.450 |
Why?
|
| Paracrine Communication | 2 | 2014 | 55 | 0.450 |
Why?
|
| Monocytes | 2 | 2016 | 503 | 0.450 |
Why?
|
| Leukotrienes | 1 | 2013 | 33 | 0.440 |
Why?
|
| Transforming Growth Factor beta | 2 | 2014 | 445 | 0.440 |
Why?
|
| Transcription Factors | 7 | 2023 | 1525 | 0.440 |
Why?
|
| Histone Deacetylases | 2 | 2012 | 194 | 0.440 |
Why?
|
| Hypoxia | 13 | 2014 | 956 | 0.440 |
Why?
|
| Stem Cells | 5 | 2023 | 541 | 0.430 |
Why?
|
| Protein-Tyrosine Kinases | 9 | 2003 | 393 | 0.430 |
Why?
|
| Macrophages, Alveolar | 2 | 2016 | 348 | 0.430 |
Why?
|
| Phospholipases A2 | 20 | 2006 | 73 | 0.420 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2023 | 46 | 0.420 |
Why?
|
| Cell Differentiation | 14 | 2023 | 1695 | 0.420 |
Why?
|
| Macrophage Activation | 1 | 2014 | 163 | 0.420 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2021 | 337 | 0.420 |
Why?
|
| Antineoplastic Agents | 6 | 2021 | 1875 | 0.410 |
Why?
|
| Lung | 12 | 2008 | 3521 | 0.400 |
Why?
|
| YY1 Transcription Factor | 1 | 2012 | 27 | 0.390 |
Why?
|
| Head and Neck Neoplasms | 3 | 2021 | 427 | 0.390 |
Why?
|
| Neoplasms | 2 | 2023 | 2086 | 0.390 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2012 | 40 | 0.390 |
Why?
|
| Frizzled Receptors | 4 | 2010 | 22 | 0.390 |
Why?
|
| T-Lymphocytes | 2 | 2017 | 1735 | 0.380 |
Why?
|
| Vasoconstrictor Agents | 3 | 2003 | 113 | 0.380 |
Why?
|
| Ureteral Obstruction | 4 | 2021 | 54 | 0.380 |
Why?
|
| Bone Marrow Cells | 2 | 2011 | 266 | 0.380 |
Why?
|
| Humans | 71 | 2023 | 114043 | 0.380 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 11 | 2018 | 145 | 0.370 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2020 | 61 | 0.370 |
Why?
|
| NF-kappa B | 6 | 2012 | 636 | 0.370 |
Why?
|
| Kidney Tubules, Proximal | 9 | 1998 | 113 | 0.360 |
Why?
|
| MAP Kinase Signaling System | 7 | 2020 | 271 | 0.360 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 8 | 2015 | 249 | 0.360 |
Why?
|
| Kidney Tubules | 5 | 2019 | 107 | 0.350 |
Why?
|
| Cadherins | 5 | 2016 | 175 | 0.350 |
Why?
|
| Genes, ras | 3 | 2001 | 91 | 0.350 |
Why?
|
| Kidney Diseases | 5 | 2020 | 349 | 0.350 |
Why?
|
| Thiazolidinediones | 4 | 2014 | 142 | 0.350 |
Why?
|
| Fibrosis | 10 | 2023 | 452 | 0.350 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 370 | 0.340 |
Why?
|
| Wnt Proteins | 3 | 2010 | 134 | 0.340 |
Why?
|
| Acute Kidney Injury | 4 | 2020 | 637 | 0.340 |
Why?
|
| Liver | 9 | 2020 | 1633 | 0.340 |
Why?
|
| Complement Inactivating Agents | 2 | 2021 | 40 | 0.330 |
Why?
|
| Erythropoietin | 1 | 2010 | 72 | 0.330 |
Why?
|
| Medication Errors | 1 | 2010 | 88 | 0.330 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2010 | 186 | 0.330 |
Why?
|
| Epoprostenol | 4 | 2008 | 133 | 0.330 |
Why?
|
| Phosphorylation | 25 | 2018 | 1558 | 0.330 |
Why?
|
| Autocrine Communication | 2 | 2014 | 42 | 0.330 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 6 | 2004 | 58 | 0.320 |
Why?
|
| Phospholipases A2, Cytosolic | 1 | 2009 | 6 | 0.320 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2016 | 2182 | 0.320 |
Why?
|
| Gene Expression | 9 | 2014 | 1417 | 0.320 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 111 | 0.320 |
Why?
|
| Intercellular Junctions | 1 | 2008 | 33 | 0.320 |
Why?
|
| Receptors, Epoprostenol | 1 | 2008 | 6 | 0.310 |
Why?
|
| Cisplatin | 3 | 2020 | 262 | 0.310 |
Why?
|
| Isoenzymes | 7 | 2004 | 283 | 0.310 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 118 | 0.300 |
Why?
|
| Epidermal Growth Factor | 8 | 1996 | 160 | 0.300 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2012 | 1128 | 0.290 |
Why?
|
| Diagnostic Imaging | 2 | 2022 | 278 | 0.290 |
Why?
|
| Flow Cytometry | 4 | 2022 | 1075 | 0.280 |
Why?
|
| Cytochrome P-450 Enzyme System | 6 | 2008 | 108 | 0.280 |
Why?
|
| Phenotype | 8 | 2021 | 2784 | 0.280 |
Why?
|
| Protein Kinase C | 8 | 1995 | 271 | 0.270 |
Why?
|
| Immunohistochemistry | 5 | 2022 | 1624 | 0.270 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2005 | 192 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2006 | 15 | 0.270 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2006 | 15 | 0.270 |
Why?
|
| Cell Line | 15 | 2018 | 2629 | 0.260 |
Why?
|
| Male | 45 | 2023 | 55396 | 0.260 |
Why?
|
| Vasopressins | 2 | 1998 | 56 | 0.260 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 5 | 2020 | 157 | 0.260 |
Why?
|
| Calcium | 17 | 2010 | 1089 | 0.250 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2010 | 307 | 0.250 |
Why?
|
| Blotting, Western | 8 | 2019 | 1143 | 0.250 |
Why?
|
| Neoplasm Transplantation | 2 | 2016 | 227 | 0.250 |
Why?
|
| Mitogens | 1 | 2005 | 58 | 0.250 |
Why?
|
| MicroRNAs | 1 | 2011 | 600 | 0.250 |
Why?
|
| Polycystic Kidney Diseases | 2 | 2023 | 55 | 0.240 |
Why?
|
| Extracellular Matrix | 4 | 2016 | 436 | 0.240 |
Why?
|
| Oncogenes | 2 | 2023 | 104 | 0.240 |
Why?
|
| Biomarkers, Tumor | 2 | 2022 | 1032 | 0.240 |
Why?
|
| Myofibroblasts | 2 | 2023 | 115 | 0.230 |
Why?
|
| Hypertension, Pulmonary | 7 | 2013 | 1736 | 0.230 |
Why?
|
| Microfilament Proteins | 2 | 2014 | 125 | 0.230 |
Why?
|
| Complement C3a | 2 | 2019 | 33 | 0.230 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2018 | 695 | 0.230 |
Why?
|
| Neoplasm Proteins | 3 | 2020 | 385 | 0.220 |
Why?
|
| Arachidonic Acid | 11 | 2016 | 112 | 0.220 |
Why?
|
| Respiratory Mucosa | 2 | 2008 | 251 | 0.220 |
Why?
|
| Seat Belts | 1 | 2023 | 18 | 0.220 |
Why?
|
| Enzyme Induction | 4 | 2008 | 83 | 0.220 |
Why?
|
| Fatty Acid Synthases | 1 | 2023 | 23 | 0.220 |
Why?
|
| Bone Marrow | 2 | 2017 | 243 | 0.220 |
Why?
|
| GTP-Binding Proteins | 4 | 2001 | 139 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2014 | 397 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 6 | 2020 | 845 | 0.210 |
Why?
|
| Cytokines | 4 | 2021 | 1824 | 0.210 |
Why?
|
| Group II Phospholipases A2 | 2 | 2012 | 16 | 0.210 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 2021 | 36 | 0.210 |
Why?
|
| Hypercholesterolemia | 1 | 2023 | 90 | 0.210 |
Why?
|
| RNA, Small Interfering | 4 | 2010 | 534 | 0.210 |
Why?
|
| Liver Regeneration | 2 | 1995 | 29 | 0.200 |
Why?
|
| Mutation | 6 | 2023 | 3338 | 0.200 |
Why?
|
| Angiotensin II | 5 | 2019 | 87 | 0.200 |
Why?
|
| Antigen Presentation | 1 | 2023 | 188 | 0.200 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2022 | 4 | 0.200 |
Why?
|
| Coculture Techniques | 2 | 2014 | 198 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2020 | 113 | 0.200 |
Why?
|
| Cell Division | 9 | 2003 | 754 | 0.200 |
Why?
|
| Homeodomain Proteins | 4 | 2014 | 463 | 0.200 |
Why?
|
| Lymphocyte Depletion | 2 | 2019 | 115 | 0.190 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2021 | 13 | 0.190 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2021 | 16 | 0.190 |
Why?
|
| Tryptophan | 1 | 2023 | 136 | 0.190 |
Why?
|
| Nephritis | 1 | 2021 | 20 | 0.190 |
Why?
|
| Sp1 Transcription Factor | 1 | 2001 | 23 | 0.190 |
Why?
|
| Gene Expression Profiling | 7 | 2019 | 1519 | 0.190 |
Why?
|
| Enzyme Inhibitors | 5 | 2012 | 743 | 0.190 |
Why?
|
| Epigenesis, Genetic | 3 | 2023 | 517 | 0.190 |
Why?
|
| Cyclic AMP | 5 | 1996 | 225 | 0.190 |
Why?
|
| Muscle Proteins | 1 | 2003 | 210 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2001 | 47 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2023 | 784 | 0.190 |
Why?
|
| Gene Silencing | 2 | 2019 | 171 | 0.190 |
Why?
|
| Radiation Tolerance | 2 | 2019 | 92 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-sis | 4 | 2005 | 33 | 0.180 |
Why?
|
| Chemokines | 2 | 2016 | 215 | 0.180 |
Why?
|
| Insulin | 16 | 1988 | 2080 | 0.180 |
Why?
|
| I-kappa B Proteins | 1 | 2001 | 80 | 0.180 |
Why?
|
| Complement C3 | 2 | 2021 | 188 | 0.180 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 13 | 0.180 |
Why?
|
| RNA, Messenger | 9 | 2012 | 2550 | 0.170 |
Why?
|
| Inflammation Mediators | 2 | 2021 | 475 | 0.170 |
Why?
|
| ras Proteins | 3 | 2012 | 138 | 0.170 |
Why?
|
| Tumor Burden | 5 | 2021 | 258 | 0.170 |
Why?
|
| Radioimmunotherapy | 1 | 2019 | 11 | 0.170 |
Why?
|
| Complement Factor H | 1 | 2020 | 60 | 0.170 |
Why?
|
| Phospholipases | 2 | 1990 | 12 | 0.170 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2019 | 11 | 0.160 |
Why?
|
| Chemokine CXCL9 | 1 | 2019 | 21 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 3 | 2015 | 438 | 0.160 |
Why?
|
| Ribosomal Proteins | 5 | 1988 | 70 | 0.160 |
Why?
|
| Iloprost | 2 | 2010 | 46 | 0.160 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2019 | 52 | 0.160 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2018 | 6 | 0.160 |
Why?
|
| Metabolome | 1 | 2021 | 274 | 0.160 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 123 | 0.160 |
Why?
|
| Tunica Intima | 2 | 2010 | 78 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 210 | 0.160 |
Why?
|
| Cell Dedifferentiation | 2 | 2016 | 28 | 0.160 |
Why?
|
| gamma Catenin | 1 | 2018 | 17 | 0.150 |
Why?
|
| Protein Isoforms | 2 | 2018 | 337 | 0.150 |
Why?
|
| Desmoglein 3 | 1 | 2018 | 17 | 0.150 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 347 | 0.150 |
Why?
|
| Metaplasia | 1 | 2018 | 54 | 0.150 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2018 | 26 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 924 | 0.150 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2018 | 54 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2010 | 388 | 0.150 |
Why?
|
| Bronchial Diseases | 1 | 2018 | 35 | 0.150 |
Why?
|
| Receptor, Insulin | 8 | 1988 | 93 | 0.150 |
Why?
|
| Female | 17 | 2023 | 59325 | 0.150 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 172 | 0.150 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2018 | 84 | 0.150 |
Why?
|
| Proteins | 6 | 2006 | 906 | 0.150 |
Why?
|
| Liver Neoplasms, Experimental | 5 | 1988 | 26 | 0.150 |
Why?
|
| Neoplasm Metastasis | 3 | 2014 | 521 | 0.150 |
Why?
|
| Virulence Factors, Bordetella | 2 | 2001 | 19 | 0.140 |
Why?
|
| Pertussis Toxin | 2 | 2001 | 24 | 0.140 |
Why?
|
| Antibodies, Blocking | 1 | 2017 | 32 | 0.140 |
Why?
|
| Interleukin-33 | 1 | 2017 | 38 | 0.140 |
Why?
|
| Complement C3d | 1 | 2017 | 60 | 0.140 |
Why?
|
| Fibroblasts | 5 | 2003 | 834 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2021 | 686 | 0.140 |
Why?
|
| Protein Binding | 3 | 2018 | 1888 | 0.140 |
Why?
|
| Vascular Diseases | 1 | 2019 | 233 | 0.140 |
Why?
|
| Bronchi | 1 | 2018 | 223 | 0.140 |
Why?
|
| Luciferases | 3 | 2010 | 142 | 0.140 |
Why?
|
| Reperfusion Injury | 2 | 2011 | 252 | 0.140 |
Why?
|
| Nephrosclerosis | 1 | 2016 | 6 | 0.140 |
Why?
|
| Energy Metabolism | 1 | 2021 | 727 | 0.140 |
Why?
|
| Tetradecanoylphorbol Acetate | 10 | 1995 | 151 | 0.140 |
Why?
|
| Rats, Inbred Strains | 12 | 1991 | 360 | 0.130 |
Why?
|
| Apoptosis | 5 | 2020 | 2349 | 0.130 |
Why?
|
| Adventitia | 1 | 2016 | 37 | 0.130 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 504 | 0.130 |
Why?
|
| Point Mutation | 1 | 1997 | 216 | 0.130 |
Why?
|
| Immunoglobulin M | 1 | 2017 | 245 | 0.130 |
Why?
|
| Vasoconstriction | 1 | 1997 | 177 | 0.130 |
Why?
|
| Molecular Weight | 13 | 1996 | 328 | 0.130 |
Why?
|
| Organ Culture Techniques | 2 | 2007 | 140 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2010 | 328 | 0.130 |
Why?
|
| Optical Imaging | 1 | 2016 | 52 | 0.130 |
Why?
|
| Immunocompetence | 1 | 2016 | 40 | 0.130 |
Why?
|
| Time Factors | 8 | 2021 | 6077 | 0.130 |
Why?
|
| Coronary Vessels | 1 | 2018 | 234 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2005 | 742 | 0.130 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2017 | 176 | 0.130 |
Why?
|
| Cell Hypoxia | 3 | 2002 | 221 | 0.130 |
Why?
|
| Colforsin | 1 | 1995 | 47 | 0.130 |
Why?
|
| Transcription, Genetic | 4 | 2014 | 1310 | 0.130 |
Why?
|
| Receptors, Growth Factor | 1 | 1995 | 49 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 4 | 2021 | 1144 | 0.120 |
Why?
|
| Endothelium, Vascular | 4 | 2018 | 830 | 0.120 |
Why?
|
| Culture Media, Conditioned | 2 | 2014 | 103 | 0.120 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 131 | 0.120 |
Why?
|
| Biopsy | 1 | 2018 | 1024 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 314 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 393 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 549 | 0.120 |
Why?
|
| Retinoid X Receptors | 1 | 2014 | 39 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2016 | 175 | 0.120 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2014 | 59 | 0.120 |
Why?
|
| Pleural Neoplasms | 1 | 2014 | 18 | 0.120 |
Why?
|
| Phagocytes | 1 | 2014 | 90 | 0.110 |
Why?
|
| Oxidants | 1 | 2014 | 112 | 0.110 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 2783 | 0.110 |
Why?
|
| Arachidonic Acids | 2 | 1991 | 56 | 0.110 |
Why?
|
| Kinetics | 15 | 2001 | 1547 | 0.110 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2014 | 17 | 0.110 |
Why?
|
| Mesothelioma | 1 | 2014 | 31 | 0.110 |
Why?
|
| Gene Amplification | 1 | 2014 | 95 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 48 | 0.110 |
Why?
|
| Tenascin | 2 | 2004 | 12 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 684 | 0.110 |
Why?
|
| Complement System Proteins | 1 | 2016 | 281 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2012 | 1836 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 486 | 0.110 |
Why?
|
| Pulmonary Artery | 6 | 2005 | 1024 | 0.110 |
Why?
|
| Hyperplasia | 2 | 2018 | 163 | 0.110 |
Why?
|
| Hypoglycemic Agents | 2 | 2011 | 1011 | 0.110 |
Why?
|
| Gene Deletion | 2 | 2013 | 356 | 0.110 |
Why?
|
| Mucous Membrane | 1 | 2014 | 108 | 0.110 |
Why?
|
| Organophosphorus Compounds | 2 | 2020 | 72 | 0.110 |
Why?
|
| Mesoderm | 3 | 2010 | 138 | 0.110 |
Why?
|
| Arteries | 2 | 2020 | 246 | 0.100 |
Why?
|
| Muscle, Smooth | 2 | 2023 | 142 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 167 | 0.100 |
Why?
|
| Protein Stability | 2 | 2014 | 156 | 0.100 |
Why?
|
| Femoral Artery | 1 | 2014 | 165 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-raf | 3 | 1997 | 43 | 0.100 |
Why?
|
| Amino Acid Sequence | 5 | 2018 | 1981 | 0.100 |
Why?
|
| Calpain | 3 | 1997 | 53 | 0.100 |
Why?
|
| Neutrophils | 2 | 2014 | 1089 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 500 | 0.100 |
Why?
|
| Glycine | 4 | 1997 | 152 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 301 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2003 | 315 | 0.090 |
Why?
|
| Colitis | 1 | 2014 | 223 | 0.090 |
Why?
|
| Splenectomy | 1 | 2011 | 51 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1257 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2012 | 256 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 396 | 0.090 |
Why?
|
| Biomarkers | 3 | 2017 | 3397 | 0.090 |
Why?
|
| Cell Migration Inhibition | 1 | 2010 | 13 | 0.090 |
Why?
|
| Imidazoles | 4 | 2014 | 203 | 0.090 |
Why?
|
| Growth Inhibitors | 1 | 2010 | 43 | 0.090 |
Why?
|
| Astragalus Plant | 1 | 2010 | 1 | 0.090 |
Why?
|
| Angelica sinensis | 1 | 2010 | 2 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 5 | 2001 | 164 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2012 | 197 | 0.090 |
Why?
|
| Snail Family Transcription Factors | 1 | 2010 | 19 | 0.090 |
Why?
|
| Renal Agents | 1 | 2010 | 5 | 0.090 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 13 | 0.090 |
Why?
|
| Protamine Kinase | 4 | 1988 | 8 | 0.090 |
Why?
|
| Mice, Nude | 3 | 2019 | 628 | 0.090 |
Why?
|
| Cell Adhesion | 2 | 2010 | 426 | 0.090 |
Why?
|
| Mitochondria | 2 | 2014 | 744 | 0.090 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2008 | 72 | 0.090 |
Why?
|
| Ventricular Remodeling | 1 | 2012 | 224 | 0.080 |
Why?
|
| Models, Animal | 1 | 2011 | 340 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 77 | 0.080 |
Why?
|
| Carotid Artery Injuries | 1 | 2010 | 44 | 0.080 |
Why?
|
| Injections | 1 | 2010 | 160 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 2 | 2021 | 170 | 0.080 |
Why?
|
| Lipoproteins, LDL | 1 | 2009 | 127 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 89 | 0.080 |
Why?
|
| ErbB Receptors | 3 | 2023 | 554 | 0.080 |
Why?
|
| Metabolomics | 1 | 2013 | 511 | 0.080 |
Why?
|
| Adenosine Triphosphatases | 1 | 2009 | 152 | 0.080 |
Why?
|
| Lung Injury | 1 | 2011 | 192 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2011 | 673 | 0.080 |
Why?
|
| Cell Shape | 1 | 2008 | 54 | 0.080 |
Why?
|
| Microsomes | 3 | 2004 | 24 | 0.080 |
Why?
|
| Cation Transport Proteins | 1 | 2009 | 123 | 0.080 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2019 | 188 | 0.080 |
Why?
|
| Smad3 Protein | 1 | 2008 | 41 | 0.080 |
Why?
|
| Smad2 Protein | 1 | 2008 | 33 | 0.080 |
Why?
|
| Cations, Divalent | 4 | 1995 | 51 | 0.080 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2008 | 63 | 0.080 |
Why?
|
| Electric Impedance | 1 | 2008 | 100 | 0.080 |
Why?
|
| Prognosis | 1 | 2016 | 3315 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2010 | 304 | 0.080 |
Why?
|
| Combined Modality Therapy | 2 | 2023 | 1117 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 338 | 0.070 |
Why?
|
| Nurses | 1 | 2010 | 145 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 159 | 0.070 |
Why?
|
| Sulindac | 1 | 2007 | 17 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 48 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2008 | 78 | 0.070 |
Why?
|
| Base Sequence | 4 | 2005 | 2114 | 0.070 |
Why?
|
| Cellular Microenvironment | 2 | 2021 | 77 | 0.070 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 2 | 2004 | 21 | 0.070 |
Why?
|
| Tyrosine | 4 | 1993 | 210 | 0.070 |
Why?
|
| Culture Media | 1 | 2007 | 155 | 0.070 |
Why?
|
| Membrane Proteins | 3 | 2004 | 1016 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 1 | 2008 | 162 | 0.070 |
Why?
|
| Cell Size | 2 | 2005 | 79 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 271 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2008 | 802 | 0.070 |
Why?
|
| Adipose Tissue | 4 | 1983 | 545 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 1228 | 0.070 |
Why?
|
| Transgenes | 1 | 2007 | 170 | 0.070 |
Why?
|
| Neoplasms, Experimental | 1 | 2007 | 149 | 0.070 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 60 | 0.070 |
Why?
|
| beta Catenin | 1 | 2008 | 218 | 0.070 |
Why?
|
| L-Lactate Dehydrogenase | 6 | 1998 | 107 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2019 | 1218 | 0.070 |
Why?
|
| Transcriptional Activation | 2 | 2005 | 337 | 0.070 |
Why?
|
| Chromatography, Ion Exchange | 5 | 1998 | 48 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 428 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 527 | 0.070 |
Why?
|
| Muscle Contraction | 2 | 2003 | 388 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 341 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 250 | 0.070 |
Why?
|
| Acetyltransferases | 1 | 2006 | 20 | 0.060 |
Why?
|
| Butylated Hydroxytoluene | 1 | 2006 | 31 | 0.060 |
Why?
|
| Hepatocyte Growth Factor | 2 | 1996 | 32 | 0.060 |
Why?
|
| Models, Biological | 3 | 2003 | 1611 | 0.060 |
Why?
|
| Pyridines | 3 | 2012 | 419 | 0.060 |
Why?
|
| Genes, jun | 1 | 2005 | 9 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 2 | 2004 | 174 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2005 | 4 | 0.060 |
Why?
|
| Substrate Specificity | 4 | 1996 | 350 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 34 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 147 | 0.060 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2005 | 14 | 0.060 |
Why?
|
| Reference Values | 4 | 1998 | 739 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 52 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2005 | 15 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2006 | 117 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 72 | 0.060 |
Why?
|
| Prostaglandin-E Synthases | 1 | 2004 | 6 | 0.060 |
Why?
|
| Cluster Analysis | 2 | 2022 | 452 | 0.060 |
Why?
|
| Nerve Growth Factor | 1 | 2004 | 27 | 0.060 |
Why?
|
| Isoproterenol | 4 | 1994 | 105 | 0.060 |
Why?
|
| Adult | 4 | 2023 | 30375 | 0.060 |
Why?
|
| NADPH Oxidase 2 | 2 | 2014 | 42 | 0.060 |
Why?
|
| Stress, Mechanical | 2 | 2003 | 445 | 0.060 |
Why?
|
| Chromatography, Gel | 5 | 1996 | 122 | 0.060 |
Why?
|
| Genes, Homeobox | 1 | 2004 | 51 | 0.060 |
Why?
|
| Cell Polarity | 1 | 2005 | 131 | 0.060 |
Why?
|
| NADPH Oxidases | 2 | 2014 | 105 | 0.060 |
Why?
|
| Pyrimidines | 2 | 2020 | 374 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2005 | 320 | 0.060 |
Why?
|
| Drosophila | 1 | 2005 | 133 | 0.060 |
Why?
|
| Corn Oil | 1 | 2023 | 3 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2001 | 145 | 0.060 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2003 | 6 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2023 | 38 | 0.050 |
Why?
|
| Genotype | 1 | 2008 | 1757 | 0.050 |
Why?
|
| Aged | 2 | 2018 | 18969 | 0.050 |
Why?
|
| Aorta | 2 | 1998 | 388 | 0.050 |
Why?
|
| B7-1 Antigen | 1 | 2023 | 53 | 0.050 |
Why?
|
| Peroxidases | 1 | 2003 | 25 | 0.050 |
Why?
|
| Peroxidase | 2 | 2015 | 161 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1846 | 0.050 |
Why?
|
| Proprotein Convertase 9 | 1 | 2023 | 61 | 0.050 |
Why?
|
| Smoke | 1 | 2004 | 123 | 0.050 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2003 | 21 | 0.050 |
Why?
|
| Tryptophan Oxygenase | 1 | 2023 | 22 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 371 | 0.050 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2023 | 44 | 0.050 |
Why?
|
| Aniline Compounds | 1 | 2023 | 70 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2001 | 345 | 0.050 |
Why?
|
| Middle Aged | 3 | 2018 | 26605 | 0.050 |
Why?
|
| In Vitro Techniques | 9 | 1998 | 1003 | 0.050 |
Why?
|
| DNA | 2 | 2003 | 1350 | 0.050 |
Why?
|
| Kynurenine | 1 | 2023 | 81 | 0.050 |
Why?
|
| Zebrafish | 1 | 2006 | 412 | 0.050 |
Why?
|
| Placenta | 3 | 1987 | 628 | 0.050 |
Why?
|
| Membrane Glycoproteins | 2 | 2014 | 429 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2023 | 133 | 0.050 |
Why?
|
| Ribosomal Protein S6 | 5 | 1988 | 15 | 0.050 |
Why?
|
| Cholesterol | 1 | 2023 | 368 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2003 | 227 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2001 | 152 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 1996 | 507 | 0.050 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2001 | 52 | 0.050 |
Why?
|
| Endothelial Cells | 2 | 2022 | 677 | 0.040 |
Why?
|
| Flavonoids | 1 | 2001 | 66 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2020 | 64 | 0.040 |
Why?
|
| Chemokine CCL2 | 2 | 2014 | 104 | 0.040 |
Why?
|
| Cetuximab | 1 | 2021 | 90 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 1 | 2021 | 217 | 0.040 |
Why?
|
| Leukocytes | 1 | 2021 | 272 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 2 | 1998 | 209 | 0.040 |
Why?
|
| Cytoplasm | 2 | 2018 | 255 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 1 | 2020 | 51 | 0.040 |
Why?
|
| Aorta, Thoracic | 3 | 2001 | 257 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2001 | 256 | 0.040 |
Why?
|
| Butadienes | 1 | 2020 | 30 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2014 | 523 | 0.040 |
Why?
|
| Lipocalin-2 | 1 | 2020 | 61 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 333 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 151 | 0.040 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2019 | 30 | 0.040 |
Why?
|
| Binding Sites | 2 | 2018 | 1166 | 0.040 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2019 | 66 | 0.040 |
Why?
|
| Chromatin | 1 | 2023 | 424 | 0.040 |
Why?
|
| Intracellular Membranes | 2 | 1993 | 73 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2006 | 690 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2020 | 88 | 0.040 |
Why?
|
| Nitric Oxide Donors | 1 | 1999 | 15 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 1983 | 694 | 0.040 |
Why?
|
| Nitriles | 1 | 2020 | 149 | 0.040 |
Why?
|
| Chemokine CXCL1 | 2 | 2011 | 67 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 146 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2001 | 777 | 0.040 |
Why?
|
| Azacitidine | 1 | 2020 | 129 | 0.040 |
Why?
|
| Receptors, Leukotriene | 1 | 2019 | 13 | 0.040 |
Why?
|
| Cathepsins | 2 | 1996 | 22 | 0.040 |
Why?
|
| Pyridones | 1 | 2020 | 122 | 0.040 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 56 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2021 | 316 | 0.040 |
Why?
|
| Nitric Oxide | 3 | 2003 | 817 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2012 | 594 | 0.040 |
Why?
|
| Homeostasis | 1 | 2022 | 570 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 636 | 0.040 |
Why?
|
| COS Cells | 1 | 2018 | 175 | 0.040 |
Why?
|
| Superoxides | 2 | 2014 | 190 | 0.040 |
Why?
|
| Myosins | 2 | 1997 | 125 | 0.040 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2018 | 8 | 0.040 |
Why?
|
| TRPP Cation Channels | 1 | 2018 | 63 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 801 | 0.040 |
Why?
|
| Phospholipids | 4 | 1994 | 194 | 0.040 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 1998 | 11 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2003 | 1311 | 0.040 |
Why?
|
| Pulmonary Circulation | 1 | 2000 | 407 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2018 | 84 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2019 | 313 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2018 | 175 | 0.040 |
Why?
|
| Trypsin | 3 | 1993 | 66 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 1997 | 76 | 0.040 |
Why?
|
| Cell-Free System | 2 | 1995 | 47 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2018 | 186 | 0.030 |
Why?
|
| Clone Cells | 2 | 2014 | 247 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 274 | 0.030 |
Why?
|
| Muscles | 3 | 1986 | 320 | 0.030 |
Why?
|
| Cell Separation | 1 | 2018 | 290 | 0.030 |
Why?
|
| Adenosine Triphosphate | 4 | 1994 | 428 | 0.030 |
Why?
|
| Neurites | 1 | 1996 | 43 | 0.030 |
Why?
|
| Acidosis, Renal Tubular | 1 | 1996 | 5 | 0.030 |
Why?
|
| Collagen | 2 | 1999 | 414 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 590 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2012 | 270 | 0.030 |
Why?
|
| Epithelium | 1 | 1997 | 295 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 1994 | 150 | 0.030 |
Why?
|
| Chemical Fractionation | 1 | 1995 | 28 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2018 | 552 | 0.030 |
Why?
|
| Cathepsin B | 1 | 1995 | 14 | 0.030 |
Why?
|
| Kidney Cortex | 1 | 1995 | 23 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 98 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1995 | 60 | 0.030 |
Why?
|
| Endopeptidases | 1 | 1995 | 70 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 140 | 0.030 |
Why?
|
| Homozygote | 1 | 2015 | 187 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2010 | 359 | 0.030 |
Why?
|
| Peptide Mapping | 2 | 1993 | 60 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1994 | 38 | 0.030 |
Why?
|
| Peptide Fragments | 4 | 1993 | 665 | 0.030 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 5 | 0.030 |
Why?
|
| Renin-Angiotensin System | 1 | 1995 | 72 | 0.030 |
Why?
|
| Calcimycin | 2 | 1995 | 47 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2015 | 234 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 2537 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2020 | 642 | 0.030 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2014 | 29 | 0.030 |
Why?
|
| Cattle | 3 | 2002 | 918 | 0.030 |
Why?
|
| Plastics | 1 | 1994 | 36 | 0.030 |
Why?
|
| Laminin | 1 | 1994 | 69 | 0.030 |
Why?
|
| Dibucaine | 1 | 1994 | 1 | 0.030 |
Why?
|
| Quinacrine | 1 | 1994 | 7 | 0.030 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 1994 | 8 | 0.030 |
Why?
|
| Pyridazines | 1 | 2014 | 46 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2014 | 82 | 0.030 |
Why?
|
| Computational Biology | 1 | 2018 | 528 | 0.030 |
Why?
|
| Proteoglycans | 1 | 1994 | 107 | 0.030 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2014 | 29 | 0.030 |
Why?
|
| RNA | 1 | 2019 | 807 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 1995 | 210 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 118 | 0.030 |
Why?
|
| Receptors, Vasopressin | 1 | 1993 | 18 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1994 | 286 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1993 | 169 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2014 | 68 | 0.030 |
Why?
|
| Thermolysin | 1 | 1993 | 3 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 2 | 2003 | 27 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2017 | 414 | 0.030 |
Why?
|
| Thrombin | 1 | 1994 | 129 | 0.030 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2003 | 27 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 205 | 0.030 |
Why?
|
| Inositol Phosphates | 2 | 1990 | 23 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1993 | 70 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2014 | 349 | 0.030 |
Why?
|
| Piperidines | 1 | 1994 | 159 | 0.030 |
Why?
|
| Quinolones | 1 | 1994 | 97 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2012 | 102 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 1995 | 380 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2014 | 440 | 0.020 |
Why?
|
| Cell Communication | 1 | 2014 | 277 | 0.020 |
Why?
|
| Colon | 1 | 2014 | 232 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1993 | 287 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2014 | 367 | 0.020 |
Why?
|
| Capillary Leak Syndrome | 1 | 2011 | 12 | 0.020 |
Why?
|
| Oxygenases | 1 | 1991 | 9 | 0.020 |
Why?
|
| Lipoxygenase | 1 | 1991 | 12 | 0.020 |
Why?
|
| Benzamides | 1 | 2012 | 168 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 385 | 0.020 |
Why?
|
| Pregnancy | 3 | 2016 | 5499 | 0.020 |
Why?
|
| Immunoblotting | 2 | 2004 | 282 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 1469 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 2 | 2001 | 42 | 0.020 |
Why?
|
| Hydrolases | 1 | 1991 | 51 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3003 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1381 | 0.020 |
Why?
|
| Inositol | 1 | 1990 | 23 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1993 | 613 | 0.020 |
Why?
|
| Phorbol Esters | 2 | 1987 | 15 | 0.020 |
Why?
|
| Plant Roots | 1 | 2010 | 34 | 0.020 |
Why?
|
| Copper-transporting ATPases | 1 | 2009 | 5 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 421 | 0.020 |
Why?
|
| Diglycerides | 1 | 1990 | 53 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 1990 | 132 | 0.020 |
Why?
|
| NAD | 1 | 1990 | 63 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1989 | 53 | 0.020 |
Why?
|
| Blood Vessels | 2 | 2002 | 179 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 1994 | 965 | 0.020 |
Why?
|
| Phytotherapy | 1 | 2010 | 67 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 6195 | 0.020 |
Why?
|
| Spleen | 1 | 2011 | 485 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 1014 | 0.020 |
Why?
|
| Oxygen | 1 | 2014 | 851 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 293 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 328 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1993 | 723 | 0.020 |
Why?
|
| Phosphates | 1 | 2010 | 155 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 1162 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2010 | 368 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2011 | 368 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 1988 | 40 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2004 | 990 | 0.020 |
Why?
|
| Heart Ventricles | 2 | 2012 | 723 | 0.020 |
Why?
|
| Chromatography, Affinity | 2 | 1989 | 80 | 0.020 |
Why?
|
| Glucagon | 1 | 1988 | 92 | 0.020 |
Why?
|
| Growth Substances | 2 | 1986 | 138 | 0.020 |
Why?
|
| Hepatectomy | 1 | 1988 | 118 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 391 | 0.020 |
Why?
|
| Neurons | 3 | 1996 | 1277 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 283 | 0.020 |
Why?
|
| Ischemia | 1 | 1991 | 361 | 0.020 |
Why?
|
| Manganese | 2 | 1987 | 55 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2014 | 1068 | 0.020 |
Why?
|
| Aging | 1 | 1997 | 1611 | 0.020 |
Why?
|
| Bucladesine | 2 | 1984 | 24 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 1987 | 26 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 1998 | 38 | 0.020 |
Why?
|
| Hypertension | 1 | 1995 | 1052 | 0.020 |
Why?
|
| Solubility | 2 | 1986 | 223 | 0.020 |
Why?
|
| Chemokine CXCL2 | 1 | 2007 | 41 | 0.020 |
Why?
|
| Ornithine Decarboxylase | 1 | 1987 | 9 | 0.020 |
Why?
|
| Ionomycin | 2 | 1997 | 24 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2009 | 917 | 0.020 |
Why?
|
| Chemokine CCL8 | 1 | 2006 | 3 | 0.020 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2006 | 8 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 2005 | 45 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2005 | 31 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2012 | 1531 | 0.020 |
Why?
|
| Acetylation | 1 | 2006 | 209 | 0.020 |
Why?
|
| Enzymes | 1 | 2005 | 62 | 0.020 |
Why?
|
| Brain | 1 | 1996 | 2355 | 0.020 |
Why?
|
| Carcinogens | 1 | 2005 | 102 | 0.020 |
Why?
|
| Heart Failure | 1 | 2018 | 1958 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 215 | 0.020 |
Why?
|
| Synapsins | 1 | 2004 | 12 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2006 | 200 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2004 | 37 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2005 | 80 | 0.010 |
Why?
|
| Species Specificity | 1 | 2005 | 541 | 0.010 |
Why?
|
| DNA Replication | 1 | 2005 | 202 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2004 | 20 | 0.010 |
Why?
|
| Propranolol | 1 | 1984 | 46 | 0.010 |
Why?
|
| Prostaglandins | 1 | 2004 | 77 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 280 | 0.010 |
Why?
|
| Phosphoproteins | 2 | 1984 | 293 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1983 | 13 | 0.010 |
Why?
|
| Magnesium | 1 | 1984 | 144 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2004 | 192 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1983 | 54 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2006 | 580 | 0.010 |
Why?
|
| Bronchiolitis | 1 | 2004 | 81 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2003 | 93 | 0.010 |
Why?
|
| Bile Ducts | 1 | 2003 | 68 | 0.010 |
Why?
|
| Perfusion | 1 | 2003 | 147 | 0.010 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 1982 | 3 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2003 | 166 | 0.010 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 1982 | 33 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2004 | 286 | 0.010 |
Why?
|
| Ligases | 1 | 1982 | 30 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 213 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2002 | 116 | 0.010 |
Why?
|
| Antioxidants | 1 | 2006 | 529 | 0.010 |
Why?
|
| Nucleotides | 1 | 2002 | 112 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1984 | 350 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 372 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 465 | 0.010 |
Why?
|
| Alleles | 1 | 2004 | 789 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2001 | 8 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2001 | 15 | 0.010 |
Why?
|
| Weight Gain | 1 | 2004 | 453 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2001 | 18 | 0.010 |
Why?
|
| Rubidium | 1 | 1980 | 12 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 796 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1980 | 43 | 0.010 |
Why?
|
| Amino Acids | 1 | 1984 | 445 | 0.010 |
Why?
|
| Tunica Media | 1 | 1999 | 35 | 0.010 |
Why?
|
| Potassium | 2 | 1996 | 127 | 0.010 |
Why?
|
| Molsidomine | 1 | 1999 | 4 | 0.010 |
Why?
|
| Opossums | 1 | 1999 | 10 | 0.010 |
Why?
|
| LLC-PK1 Cells | 1 | 1999 | 16 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 1999 | 78 | 0.010 |
Why?
|
| Nitrates | 1 | 1999 | 71 | 0.010 |
Why?
|
| Body Weight | 1 | 2003 | 868 | 0.010 |
Why?
|
| Myocardium | 1 | 1984 | 911 | 0.010 |
Why?
|
| Fibronectins | 1 | 1999 | 108 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2003 | 1015 | 0.010 |
Why?
|
| Benzoates | 1 | 1998 | 38 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 1998 | 25 | 0.010 |
Why?
|
| Cell Death | 1 | 2000 | 322 | 0.010 |
Why?
|
| Endothelin-1 | 1 | 1999 | 168 | 0.010 |
Why?
|
| Spectrin | 1 | 1997 | 13 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1999 | 222 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 1998 | 157 | 0.010 |
Why?
|
| Ascites | 1 | 1998 | 32 | 0.010 |
Why?
|
| Cytoprotection | 1 | 1997 | 51 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 1998 | 181 | 0.010 |
Why?
|
| Asparagine | 1 | 1977 | 29 | 0.010 |
Why?
|
| Mammals | 1 | 1999 | 241 | 0.010 |
Why?
|
| Swine | 1 | 1999 | 687 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1996 | 77 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1996 | 53 | 0.010 |
Why?
|
| Acrylates | 1 | 1996 | 45 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1996 | 9 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1996 | 91 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1996 | 27 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1996 | 37 | 0.010 |
Why?
|
| Ethylmaleimide | 2 | 1989 | 18 | 0.010 |
Why?
|
| Cathepsin L | 1 | 1995 | 9 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2003 | 907 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1999 | 547 | 0.010 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1995 | 34 | 0.010 |
Why?
|
| Dipeptides | 1 | 1995 | 47 | 0.010 |
Why?
|
| Arginine | 1 | 1996 | 236 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1995 | 180 | 0.010 |
Why?
|
| Cholera Toxin | 1 | 1994 | 27 | 0.010 |
Why?
|
| CHO Cells | 1 | 1994 | 137 | 0.010 |
Why?
|
| Cricetinae | 1 | 1994 | 252 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 138 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1994 | 200 | 0.010 |
Why?
|
| Biological Transport | 1 | 1994 | 374 | 0.010 |
Why?
|
| Fetus | 1 | 1996 | 698 | 0.010 |
Why?
|
| Membrane Lipids | 1 | 1993 | 87 | 0.010 |
Why?
|
| Peptides | 1 | 1977 | 848 | 0.010 |
Why?
|
| Reperfusion | 1 | 1991 | 35 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 7943 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 1989 | 21 | 0.010 |
Why?
|
| Carbachol | 1 | 1987 | 21 | 0.000 |
Why?
|
| Astrocytoma | 1 | 1987 | 106 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1986 | 242 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1986 | 266 | 0.000 |
Why?
|
| Hydrolysis | 1 | 1986 | 173 | 0.000 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1984 | 27 | 0.000 |
Why?
|
| Child | 1 | 2002 | 18400 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1983 | 55 | 0.000 |
Why?
|
| Detergents | 1 | 1983 | 41 | 0.000 |
Why?
|
| Calmodulin | 1 | 1982 | 71 | 0.000 |
Why?
|
| Ouabain | 1 | 1980 | 15 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1980 | 71 | 0.000 |
Why?
|
| Potassium Cyanide | 1 | 1980 | 18 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1982 | 301 | 0.000 |
Why?
|
| Sodium | 1 | 1980 | 184 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1982 | 670 | 0.000 |
Why?
|
| Drug Stability | 1 | 1977 | 151 | 0.000 |
Why?
|
| Temperature | 1 | 1977 | 564 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1977 | 803 | 0.000 |
Why?
|
| Water | 1 | 1977 | 394 | 0.000 |
Why?
|